OPKO Health
OPK
$1.37
Share price
-2.84%
Change (1 day)
-2.14%
Change (1 year)
Categories
Earnings for OPKO Health (OPK)
Earnings in 2023 (TTM): -$0.19 B
According to OPKO Health 's latest financial reports the company's current earnings (TTM) are -$0.26 B. In 2022 the company made an earning of -$0.4 B a decrease over its 2021 earnings that were of -$14.03 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for OPKO Health from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.19 B | -52.92% |
| 2022 | -$0.4 B | 2691.58% |
| 2021 | -$14.03 M | -128.81% |
| 2020 | $48.68 M | -115.96% |
| 2019 | -$0.31 B | 72.03% |
| 2018 | -$0.18 B | -33.83% |
| 2017 | -$0.27 B | 264.29% |
| 2016 | -$73.55 M | -46.71% |
| 2015 | -$0.14 B | -19.31% |
| 2014 | -$0.18 B | 64.11% |
| 2013 | -$0.11 B | 180.06% |
| 2012 | -$37.22 M | 53.56% |
| 2011 | -$24.24 M | 55.87% |
| 2010 | -$15.55 M | -48.27% |
| 2009 | -$30.06 M | -24.64% |
| 2008 | -$39.88 M | -85.11% |
| 2007 | -$0.27 B | 6.61% |
| 2006 | -$0.26 B | 18539.02% |
| 2005 | -$1.35 M | -32.33% |
| 2004 | -$2 M | -45.53% |
| 2003 | -$3.66 M | -64.7% |
| 2002 | -$10.36 M | 2.99% |
| 2001 | -$10.06 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $21.36 B | -8,627.97% | 🇺🇸 USA |
 Abbott Laboratories ABT | $6.53 B | -2,709.93% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $4.04 B | -1,713.54% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | -$5.85 B | 2,233.69% | 🇺🇸 USA |
 LabCorp LH | $0.78 B | -415.28% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$0.2 B | -21.27% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $0.18 B | -174.25% | 🇮🇱 Israel |
 Ardelyx ARDX | -$65.16 M | -73.99% | 🇺🇸 USA |